Jeet Mukherjee
Stock Analyst at BTIG
(4.73)
# 698
Out of 4,974 analysts
143
Total ratings
58.6%
Success rate
26.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Jeet Mukherjee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| FTH Faeth Therapeutics | Reiterated: Buy | $55 | $35.37 | +55.50% | 6 | Sep 13, 2026 | |
| IPHA Innate Pharma | Reiterated: Buy | $9 | $1.86 | +383.87% | 6 | Sep 1, 2026 | |
| AAPG Ascentage Pharma Group International | Reiterated: Buy | $48 | $16.00 | +200.00% | 5 | Aug 20, 2026 | |
| AARD Aardvark Therapeutics | Reiterated: Hold | n/a | $5.02 | - | 10 | Aug 12, 2026 | |
| AVBP ArriVent BioPharma | Reiterated: Buy | $42 | $27.97 | +50.16% | 4 | Aug 12, 2026 | |
| BCAX Bicara Therapeutics | Reiterated: Buy | $28 → $39 | $22.67 | +72.03% | 7 | Aug 12, 2026 | |
| MNPR Monopar Therapeutics | Reiterated: Buy | $117 → $133 | $104.33 | +27.48% | 17 | Aug 12, 2026 | |
| CATX Perspective Therapeutics | Reiterated: Buy | $14 | $2.73 | +412.82% | 10 | Aug 11, 2026 | |
| FHTX Foghorn Therapeutics | Reiterated: Buy | $11 | $4.12 | +166.99% | 5 | Aug 6, 2026 | |
| VSTM Verastem | Reiterated: Buy | $18 | $7.34 | +145.23% | 6 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $8.14 | +47.42% | 7 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $215 | $151.22 | +42.18% | 10 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $32 | $24.83 | +28.88% | 12 | Jul 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $138 → $134 | $113.15 | +18.43% | 13 | Jun 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $18 | $8.26 | +117.92% | 12 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $29.95 | +317.36% | 5 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $11.30 | n/a | 1 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $91 | $17.67 | n/a | 2 | May 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $0.3213 | n/a | 1 | May 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $42 | $53.36 | n/a | 1 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $100 | $16.44 | n/a | 1 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $62 | $37.66 | n/a | 1 | Apr 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.0008 | n/a | 1 | Apr 1, 2025 |
Faeth Therapeutics
Sep 13, 2026
Reiterated: Buy
Price Target: $55
Current: $35.37
Upside: +55.50%
Innate Pharma
Sep 1, 2026
Reiterated: Buy
Price Target: $9
Current: $1.86
Upside: +383.87%
Ascentage Pharma Group International
Aug 20, 2026
Reiterated: Buy
Price Target: $48
Current: $16.00
Upside: +200.00%
Aardvark Therapeutics
Aug 12, 2026
Reiterated: Hold
Price Target: n/a
Current: $5.02
Upside: -
ArriVent BioPharma
Aug 12, 2026
Reiterated: Buy
Price Target: $42
Current: $27.97
Upside: +50.16%
Bicara Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $28 → $39
Current: $22.67
Upside: +72.03%
Monopar Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $117 → $133
Current: $104.33
Upside: +27.48%
Perspective Therapeutics
Aug 11, 2026
Reiterated: Buy
Price Target: $14
Current: $2.73
Upside: +412.82%
Foghorn Therapeutics
Aug 6, 2026
Reiterated: Buy
Price Target: $11
Current: $4.12
Upside: +166.99%
Verastem
Aug 6, 2026
Reiterated: Buy
Price Target: $18
Current: $7.34
Upside: +145.23%
Aug 4, 2026
Reiterated: Buy
Price Target: $12
Current: $8.14
Upside: +47.42%
Aug 4, 2026
Reiterated: Buy
Price Target: $215
Current: $151.22
Upside: +42.18%
Jul 1, 2026
Rated: Buy
Price Target: $32
Current: $24.83
Upside: +28.88%
Jun 25, 2026
Reiterated: Buy
Price Target: $138 → $134
Current: $113.15
Upside: +18.43%
May 13, 2026
Reiterated: Buy
Price Target: $16 → $18
Current: $8.26
Upside: +117.92%
May 1, 2026
Reiterated: Buy
Price Target: $125
Current: $29.95
Upside: +317.36%
May 23, 2025
Reiterated: Hold
Price Target: n/a
Current: $11.30
Upside: n/a
May 23, 2025
Reiterated: Buy
Price Target: $91
Current: $17.67
Upside: n/a
May 21, 2025
Reiterated: Buy
Price Target: $12
Current: $0.3213
Upside: n/a
May 13, 2025
Initiated Coverage: Buy
Price Target: $42
Current: $53.36
Upside: n/a
May 9, 2025
Reiterated: Buy
Price Target: $100
Current: $16.44
Upside: n/a
Apr 14, 2025
Reiterated: Buy
Price Target: $62
Current: $37.66
Upside: n/a
Apr 1, 2025
Reiterated: Hold
Price Target: n/a
Current: $0.0008
Upside: n/a